The Centre termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for Covaxin was rushed due to political pressure. Bharat Biotech also stated that there was no external pressure to accelerate development of Covaxin.
Covaxin makers Bharat Biotech also in a statement said that the targeted narrative against Covaxin is misleading and asserted that there was no external pressure to accelerate the development of Covaxin. The company clarified that the pressure was all internal to develop a safe, and effective vaccine for the Covid-19 pandemic.
AstraZeneca's nasal vaccine underperforms against COVID-19 navhindtimes.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from navhindtimes.in Daily Mail and Mail on Sunday newspapers.